# Smectite Gel and Probiotic for Obesity and Insulin Resistance

> **NCT04293731** · NA · COMPLETED · sponsor: **Bogomolets National Medical University** · enrollment: 55 (actual)

## Conditions studied

- Obesity
- Insulin Resistance
- Insulin Sensitivity
- Type2 Diabetes Mellitus
- Visceral Obesity

## Interventions

- **DIETARY_SUPPLEMENT:** Symbiter-Smectite
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT04293731
- **Lead sponsor:** Bogomolets National Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-01
- **Primary completion:** 2019-05-25
- **Final completion:** 2019-05-28
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2023-06-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04293731

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04293731, "Smectite Gel and Probiotic for Obesity and Insulin Resistance". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT04293731. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*